Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Open-Label, Multicenter Study of INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

NCT07195916 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT07195916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07195916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Open-Label, Multicenter Study of INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Lead sponsor
Incyte Corporation
Phase
Phase 1
Overall status
Recruiting
Start date
January 8, 2026
Completion date
August 18, 2028
Enrollment
280 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancies, solid tumors